Brett Kaplan

Entity
Individual
Business address
C/O Prevail Therapeutics Inc., 430 East 29 Th Street, Suite 940, 10016 New York, NY
Signature Ownership
/s/ Emily Pimblett, as Attorney-in-Fact
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Brett Kaplan has filed 9 SEC EDGAR filings since 6/19/2019

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 4 Jan 15, 2025 Jan 13, 2025 001-40708
4 Open Document Open Filing 4 Aug 26, 2024 Aug 26, 2024 001-40708
3 Open Document Open Filing 3 Aug 26, 2024 Aug 26, 2024 001-40708
4 Open Document Open Filing FORM 4 SUBMISSION Feb 23, 2022 Feb 18, 2022 001-39696
4 Open Document Open Filing FORM 4 SUBMISSION Jan 26, 2021 Jan 22, 2021 001-38939
4 Open Document Open Filing FORM 4 SUBMISSION Sep 14, 2020 Sep 10, 2020 000-55939
3 Open Document Open Filing FORM 3 SUBMISSION Sep 14, 2020 Sep 10, 2020 000-55939
4 Open Document Open Filing FORM 4 SUBMISSION Mar 11, 2020 Feb 19, 2020 001-38939
3 Open Document Open Filing FORM 3 SUBMISSION Jun 19, 2019 Jun 19, 2019 001-38939